BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 33104520)

  • 1. Single-cell expression profiles of
    Lü M; Qiu L; Jia G; Guo R; Leng Q
    Aging (Albany NY); 2020 Oct; 12(20):19880-19897. PubMed ID: 33104520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads.
    Taglauer E; Benarroch Y; Rop K; Barnett E; Sabharwal V; Yarrington C; Wachman EM
    Placenta; 2020 Oct; 100():69-74. PubMed ID: 32862058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?
    Shook LL; Bordt EA; Meinsohn MC; Pepin D; De Guzman RM; Brigida S; Yockey LJ; James KE; Sullivan MW; Bebell LM; Roberts DJ; Kaimal AJ; Li JZ; Schust D; Gray KJ; Edlow AG
    J Infect Dis; 2021 Dec; 224(Suppl 6):S647-S659. PubMed ID: 34293137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta.
    Cui D; Liu Y; Jiang X; Ding C; Poon LC; Wang H; Yang H
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):248-256. PubMed ID: 32851697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
    Pique-Regi R; Romero R; Tarca AL; Luca F; Xu Y; Alazizi A; Leng Y; Hsu CD; Gomez-Lopez N
    Elife; 2020 Jul; 9():. PubMed ID: 32662421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
    Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
    Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of SARS-CoV-2 receptor
    Weatherbee BAT; Glover DM; Zernicka-Goetz M
    Open Biol; 2020 Aug; 10(8):200162. PubMed ID: 32750256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations.
    Celik O; Celik N; Aydin S; Baysal B; Aydin S; Saglam A; Gursu Y; Dalkilic S; Ulas M; Ozcil MD; Tayyar AT; Cengiz F; Ugur K; Akkoc RF; Ersahin AA
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):221-229. PubMed ID: 32538775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
    Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
    Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
    Diriba K; Awulachew E; Getu E
    Eur J Med Res; 2020 Sep; 25(1):39. PubMed ID: 32887660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental barrier against COVID-19.
    Komine-Aizawa S; Takada K; Hayakawa S
    Placenta; 2020 Sep; 99():45-49. PubMed ID: 32755724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TMPRSS2 in SARS-CoV-2 Infection.
    Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
    Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A special on epidemic prevention and control: analysis on expression of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues].
    Zhang BN; Wang Q; Liu T; Dou SQ; Qi X; Jiang H; Qi BX; Zhang B; Zhou QJ
    Zhonghua Yan Ke Za Zhi; 2020 Jun; 56(6):438-446. PubMed ID: 32316719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
    Hecht JL; Quade B; Deshpande V; Mino-Kenudson M; Ting DT; Desai N; Dygulska B; Heyman T; Salafia C; Shen D; Bates SV; Roberts DJ
    Mod Pathol; 2020 Nov; 33(11):2092-2103. PubMed ID: 32741970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
    Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
    Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
    Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
    Öztürk AB; Çağlayan B
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.